Retatrutide has demonstrated the highest weight loss potential in clinical trials, with up to 28.7% mean body weight loss at 68 weeks
*Correspondence: Yougen Chen, [email protected] Wang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Finally, Fe 2+ is released from divalent metal transporter 1 (DMT1) mediated endosome into unstable iron pool in the cytoplasm [51]
**Setria is a registered trademark of Kyowa Hakko Bio Co., Ltd
Analysis of raw LC/MS data was performed using software package Compound Discoverer 2.0 (Thermo Fisher Scientific) with an in-house-generated analysis workflow and oxidized-phospholipid database
May be repeated daily, if indicated